Myriad Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
November 07, 2024 at 04:05 pm EST
Myriad Genetics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported net loss was USD 22.1 million compared to USD 61.3 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.75 a year ago.
For the nine months, net loss was USD 84.8 million compared to USD 232.1 million a year ago. Basic loss per share from continuing operations was USD 0.94 compared to USD 2.84 a year ago.